Menu
Back to Journals » Hepatic Medicine: Evidence and Research » Volume 14
Original Research
Post-Marketing Surveillance Study of the Safety and Efficacy of Nalfurafine (Capsules 2.5 μg, Oral Dispersing Tablets 2.5 μg) in 1186 Patients with Chronic Liver Disease and Intractable Pruritus
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 6,121 | Dovepress* | 5,902+ | 315 | 6,217 | |
| PubMed Central* | 219 | 88 | 307 | ||
| Totals | 6,121 | 403 | 6,524 | ||
| *Since 2 May 2022 | |||||
View citations on PubMed Central and Google Scholar